Hong Zhao

35PUBLICATIONS
31CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersEpidemiological modellingChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Sep 16, 2026
Oral KRAS G12D inhibitor GFH375 for previously treated advanced solid tumors with KRASG12D mutations: a phase 1 trial.

|Sep 01, 2026
Integrated single-cell multi-omics characterization reveals lipid-associated macrophage-mediated immunosuppression in neoadjuvant immunotherapy of hepatocellular carcinoma.

|Jul 25, 2026
Lenvatinib enhances the response of biliary tract cancer to anti-HER2 therapy.

|Jul 17, 2026
Effectiveness and safety of PD-1/PD-L1 inhibitors plus lenvatinib with or without Gemox chemotherapy in advanced intrahepatic cholangiocarcinoma.

|Feb 12, 2026
Development and validation of prediction model for early allograft dysfunction following liver transplantation based on systematic review and meta-analysis.

Zhihong Zheng, Shuman Kuang, Zipei Wang

|Feb 10, 2026
Efficacy and safety of pembrolizumab, lenvatinib, and reduced-dose gemcitabine/oxaliplatin as initial treatment for advanced biliary tract cancer: a multicenter, single-arm, prospective, phase II study.

Mingjian Piao, Chengjie Li, Shuofeng Li

Pageof 6

Frequent Collaborators

4 joint publications

Xinting Sang

3 joint publications

Lijin Zhao

2 joint publications

Ling Lu

2 joint publications

Jiashuo Chao